Elsa Johnson

Elsa Johnson is the Vice President of Program and Portfolio Management of Vincerx. Ms Johnson is the principal for Goal Management Consulting, a consulting company assisting small pharmaceutical startups in Seattle and the Bay Area develop and execute on their development plans, since December 2018. Before that, Ms Johnson was a senior director of program management at Acerta Pharma from June 2014 to July 2018 and was part of the initial management team that led to a successful Astra Zeneca acquisition and subsequent CALQUENCE® approval. From October 2008 to January 2014, Ms Johnson was director of project management for HemaQuest Pharmaceuticals, a clinical development stage company developing small molecules for the treatment of life-threatening hematologic disorders. From May 2006 to August 2008, Ms Johnson was a senior project manager for Nastech Pharmaceuticals, a company developing nasal delivery formulations. From December 2003 to May 2006, Ms Johnson was senior project manager at Corus Pharma where she supervised the overall cross functional activities of an inhaled antibiotic orphan drug program for the treatment of cystic fibrosis, CAYSTON®. From March 1990 to November 2003, Ms Johnson has held different positions of increasing responsibility from data management, clinical research, clinical operations management and clinical project management.

Ms Johnson received her BS in Economics from Southern Methodist University and MBA from Lake Forest Graduate School of Management.